<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7498210\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="the COVID-19 resource centre remains active. Abstract Background and Aims" exact="Severe" post="Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) induced Novel Coronavirus Disease"/>
  <result pre="COVID-19 resource centre remains active. Abstract Background and Aims Severe" exact="Acute" post="Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) induced Novel Coronavirus Disease (COVID-19)"/>
  <result pre="resource centre remains active. Abstract Background and Aims Severe Acute" exact="Respiratory" post="Syndrome Coronavirus-2 (SARS-CoV-2) induced Novel Coronavirus Disease (COVID-19) has"/>
  <result pre="centre remains active. Abstract Background and Aims Severe Acute Respiratory" exact="Syndrome" post="Coronavirus-2 (SARS-CoV-2) induced Novel Coronavirus Disease (COVID-19) has currently"/>
  <result pre="Aims Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) induced Novel Coronavirus" exact="Disease" post="(COVID-19) has currently become pandemic worldwide. Though drugs like"/>
  <result pre="protease Mpro is first published, plays a prominent role in" exact="viral" post="replication and an attractive drug-target for drug discovery. Hence,"/>
  <result pre="In silico Repurposing Mpro Docking (ARCMED_2020_864) Introduction COVID-19 is a" exact="respiratory" post="infection by SARS-CoV-2 originally seen in Wuhan city of"/>
  <result pre="silico Repurposing Mpro Docking (ARCMED_2020_864) Introduction COVID-19 is a respiratory" exact="infection" post="by SARS-CoV-2 originally seen in Wuhan city of China,"/>
  <result pre="coronavirus caused epidemics such as SARS and MERS (Middle East" exact="Respiratory" post="Syndrome) in 2013 and 2018, respectively in China, and"/>
  <result pre="and Saudi Arabia (2). COVID-19 was first recognized as intense" exact="pneumonia" post="in a medical facility in Wuhan, Hubei Province of"/>
  <result pre="haemoptysis, diarrhoea, dyspnoea, and lymphopenia. The clinical features identified by" exact="chest" post="CT-scans are pneumonia with unusual features such as RNAaemia,"/>
  <result pre="and lymphopenia. The clinical features identified by chest CT-scans are" exact="pneumonia" post="with unusual features such as RNAaemia, acute respiratory distress"/>
  <result pre="chest CT-scans are pneumonia with unusual features such as RNAaemia," exact="acute" post="respiratory distress syndrome, the occurrence of the ground-glass opacity"/>
  <result pre="CT-scans are pneumonia with unusual features such as RNAaemia, acute" exact="respiratory" post="distress syndrome, the occurrence of the ground-glass opacity and"/>
  <result pre="the mutations in virus (4). The SARS-CoV-2 spreads mainly through" exact="respiratory" post="droplets or droplet nuclei between individuals (5). Hence, social"/>
  <result pre="individuals (5). Hence, social distancing and preventing the spread by" exact="respiratory" post="droplets has become the mainstay of COVID-19 management rather"/>
  <result pre="by US-FDA for treatment of COVID-19 act by inhibiting the" exact="viral" post="RNA-dependent RNA polymerase (RdRp). These drugs have limitation in"/>
  <result pre="defined. Finally, drug-molecules were geometry minimized using OPLS3e force-field (17)." exact="Protein" post="Preparation The protein structure of major protease Mpro coordinate"/>
  <result pre="protease Mpro coordinate with accession code 6LU7 was downloaded from" exact="Protein" post="Data Bank (10). The protein structure was optimized using"/>
  <result pre="Protein Data Bank (10). The protein structure was optimized using" exact="Protein" post="Prep Wizard (PPW) tool in Shrodinger software (18). The"/>
  <result pre="(22). Molecular Dynamics Simulation Based on the molecular interaction and" exact="visual" post="analysis of SP-docking results, the top-ranked drugs were taken"/>
  <result pre="solvating the system. The orthorhombic simulation was the box with" exact="periodic" post="boundary condition generated with a buffer distance of minimum"/>
  <result pre="at 300Â°K temperature at atmospheric pressure of 1.013Â bar. A" exact="total" post="of 100 nsec simulation was run during which 1000"/>
  <result pre="the active site of Mpro. Based on docking score and" exact="visual" post="interpretations, the drugs aprepitant, barnidipine, tipiracil, arbutin, and terbutaline"/>
  <result pre="emesis, Postoperative nausea and vomiting âˆ’6.892 - HIE41 2 Barnidipine" exact="Hypertension" post="âˆ’6.421 ASN142, CYS145, GLU166(2) HIE41 3 Tipiracil Bioavailability enhancer"/>
  <result pre="CYS145, GLU166(2) HIE41 3 Tipiracil Bioavailability enhancer of Triflurudine in" exact="Colorectal cancer" post="âˆ’6.331 HIS164, HIS166 HIE41 4 Arbutin Skin-lightening agent, Hyperpigmentation"/>
  <result pre="GLU166(2) HIE41 3 Tipiracil Bioavailability enhancer of Triflurudine in Colorectal" exact="cancer" post="âˆ’6.331 HIS164, HIS166 HIE41 4 Arbutin Skin-lightening agent, Hyperpigmentation"/>
  <result pre="Further, these five drugs had significant interactions with Mpro by" exact="visual" post="investigation of their 2D and 3D poses (Supplementary FigureÂ"/>
  <result pre="aprepitant, barnidipine, tipiracil, arbutin and terbutaline. The Root Mean Square" exact="Deviations" post="(RMSD) plot analysis of the structures saved in the"/>
  <result pre="in the trajectory produced during the MD-simulation exhibited strong and" exact="stable" post="binding with Mpro for the aprepitant and tipiracil where"/>
  <result pre="terbutaline demonstrated strong binding ability and arbutin demonstrated the least" exact="stable" post="binding (FigureÂ 1 ). FigureÂ 1 The Root Mean"/>
  <result pre="binding (FigureÂ 1 ). FigureÂ 1 The Root Mean Square" exact="Deviations" post="(RMSD) plots. RMSDs for (A) Apripitant; (B) Barnidipine; (C)"/>
  <result pre="initial structure for the RMSD analysis. The protein-ligand complex was" exact="stable" post="for the entire simulation period, indicates the binding stability"/>
  <result pre="acid long and functionally inhibit replicase precursor polyproteins whereby prevent" exact="viral" post="gene expression and replication. In Mpro, there are three"/>
  <result pre="drugs, five drugs are shortlisted based on docking score and" exact="visual" post="analysis of SP-docking and MD-simulation. These drugs are first"/>
  <result pre="barnidipine, a calcium channel blocker and an antihypertensive agent was" exact="short" post="listed because of its significant interaction with Mpro (27)."/>
  <result pre="with an anticancer agent trifluridine for treatment of advanced or" exact="recurrent" post="colorectal cancer. Tipiracil prevents the degradation of trifluridine by"/>
  <result pre="an anticancer agent trifluridine for treatment of advanced or recurrent" exact="colorectal cancer." post="Tipiracil prevents the degradation of trifluridine by inhibiting the"/>
  <result pre="the tipiracil interaction with Mpro is much more durable and" exact="stable" post="in both SP-docking and molecular dynamics simulations. Thus, the"/>
  <result pre="References References 1GuoY.-R.CaoQ.-D.HongZ.-S.The origin, transmission and clinical therapies on coronavirus" exact="disease" post="2019 (COVID-19) outbreak- A n update on the statusMil"/>
  <result pre="ChinaLancet395202049750631986264 4NaqviA.A.T.FatimaK.MohammadT.Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies:" exact="Structural" post="genomics approachBiochim Biophys Acta-Mol Basis Dis1866202016587832544429 5ZhangJ.LitvinovaM.WangW.Evolving epidemiology and"/>
  <result pre="Acta-Mol Basis Dis1866202016587832544429 5ZhangJ.LitvinovaM.WangW.Evolving epidemiology and transmission dynamics of coronavirus" exact="disease" post="2019 outside Hubei province, China: a descriptive and modelling"/>
  <result pre="countriesEur J Epidemiol35202038939932430840 7CherianS.S.AgrawalM.BasuA.Perspectives for repurposing drugs for the coronavirus" exact="disease" post="2019Indian J Med Res151202016017132317408 8PilkingtonV.PepperrellT.HillA.A review of the safety"/>
  <result pre="antagonistCardiovasc Drug Rev151997273290 28ChanB.M.HochsterH.S.LenzH.-J.The safety and efficacy of trifluridineâ€&quot;tipiracil for" exact="metastatic" post="colorectal cancer: A pharmacy perspectiveAm J Heal Pharm762019339348 29PillaiyarT.ManickamM.NamasivayamV.Skin"/>
 </snippets>
</snippetsTree>
